FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2025-2033 November 10, 2005 Number 19 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Somers, V. K. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial tested the hypothesis that continuous positive airway pressure (CPAP) would improve the survival rate without heart transplantation of patients who have central sleep apnea and heart failure.

Methods After medical therapy was optimized, 258 patients who had heart failure (mean age [±SD], 63±10 years; ejection fraction, 24.5±7.7 percent) and central sleep apnea (number of episodes of apnea and hypopnea per hour of sleep, 40±16) were randomly assigned to receive CPAP (128 patients) or no CPAP (130 patients) and were followed for a mean of two years. During follow-up, sleep studies were conducted and measurements of the ejection fraction, exercise capacity, quality of life, and neurohormones were obtained.

Results Three months after undergoing randomization, the CPAP group, as compared with the control group, had greater reductions in the frequency of episodes of apnea and hypopnea (–21±16 vs. –2±18 per hour, P<0.001) and in norepinephrine levels (–1.03±1.84 vs. 0.02±0.99 nmol per liter, P=0.009), and greater increases in the mean nocturnal oxygen saturation (1.6±2.8 percent vs. 0.4±2.5 percent, P<0.001), ejection fraction (2.2±5.4 percent vs. 0.4±5.3 percent, P=0.02), and the distance walked in six minutes (20.0±55 vs. –0.8±64.8 m, P=0.016). There were no differences between the control group and the CPAP group in the number of hospitalizations, quality of life, or atrial natriuretic peptide levels. An early divergence in survival rates without heart transplantation favored the control group, but after 18 months the divergence favored the CPAP group, yet the overall event rates (death and heart transplantation) did not differ (32 vs. 32 events, respectively; P=0.54).

Conclusions Although CPAP attenuated central sleep apnea, improved nocturnal oxygenation, increased the ejection fraction, lowered norepinephrine levels, and increased the distance walked in six minutes, it did not affect survival. Our data do not support the use of CPAP to extend life in patients who have central sleep apnea and heart failure.

Source Information

From the Department of Medicine, University of Toronto, Toronto (T.D.B., A.G.L., P.H., G.T., J.S.F.); the Department of Medicine, McGill University, Montreal (R.J.K., M.S.); the Department of Medicine, Laval University, Quebec, Que. (F.S.); the Department of Medicine, Dalhousie University, Halifax, N.S. (D.M.); the Department of Medicine, University of Western Ontario, London (K.F.); the Department of Medicine, University of Calgary, Calgary, Alta. (I.B.); the Department of Medicine, University of British Columbia, Vancouver (J.F.) — all in Canada; and the Department of Medicine, University of Regensburg, Regensburg, Germany (M.P.).

Address reprint requests to Dr. Bradley at the Department of Medicine, Toronto General Hospital of the University Health Network, Room 9N-943, 200 Elizabeth St., Toronto, ON M5G 2C4, Canada, or at douglas.bradley{at}utoronto.ca.

Full Text of this Article

Related Letters:

Sleep Apnea and Heart Disease
Sinha A.-M., Skobel E. C., Breithardt O.-A., Zheng H., Zhan H., Wilcox I., Booth V., Lattimore J., Chhajed P. N., Tamm M., Strobel W., Neuberger H.-R., Böhm M., Mewis C., Bradley T. D., Floras J. S., Logan A. G., Yaggi H. K., Concato J., Mohsenin V.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:1086-1089, Mar 9, 2006. Correspondence

This article has been cited by other articles:

• Chan, C. T (2008). Reply. Nephrol Dial Transplant 0: gfn145v1-gfn145 [Full Text]  
• Ozsancak, A., D'Ambrosio, C., Hill, N. S. (2008). Nocturnal Noninvasive Ventilation. Chest 133: 1275-1286 [Abstract] [Full Text]  
• Luo, Y. M., Wu, H. D., Tang, J., Jolley, C., Steier, J., Moxham, J., Zhong, N. S., Polkey, M. I. (2008). Neural respiratory drive during apnoeic events in obstructive sleep apnoea. Eur Respir J 31: 650-657 [Abstract] [Full Text]  
• Yumino, D., Bradley, T. D. (2008). Central Sleep Apnea and Cheyne-Stokes Respiration. Proc Am Thorac Soc 5: 226-236 [Abstract] [Full Text]  
• Bradley, T. D. (2008). Respiratory Sleep Medicine: A Coming of Age. Am. J. Respir. Crit. Care Med. 177: 363-364 [Full Text]  
• Amit Benjamin, J, Lewis, K E (2008). Sleep-disordered breathing and cardiovascular disease. Postgrad. Med. J. 84: 15-22 [Abstract] [Full Text]  
• Allam, J. S., Olson, E. J., Gay, P. C., Morgenthaler, T. I. (2007). Efficacy of Adaptive Servoventilation in Treatment of Complex and Central Sleep Apnea Syndromes. Chest 132: 1839-1846 [Abstract] [Full Text]  
• Pevernagie, D., Janssens, J. P., De Backer, W., Elliott, M., Pepperell, J., Andreas, S. (2007). Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep. ERR 16: 115-124 [Abstract] [Full Text]  
• Lavie, P. (2007). Mortality in sleep apnoea syndrome: a review of the evidence. ERR 16: 203-210 [Abstract] [Full Text]  
• Oldenburg, O., Lamp, B., Freudenberg, G., Horstkotte, D. (2007). Screening for sleep-disordered breathing is recommended in patients with chronic heart failure. Eur Respir J 30: 1023-1023 [Full Text]  
• Naughton, M. T. (2007). Testing for Cheyne-Stokes Respiration in Patients With Heart Failure: While Sleeping or Cycling?. Chest 132: 1416-1418 [Full Text]  
• Chan, C. T., Notarius, C. F., Merlocco, A. C., Floras, J. S. (2007). Improvement in exercise duration and capacity after conversion to nocturnal home haemodialysis. Nephrol Dial Transplant 22: 3285-3291 [Abstract] [Full Text]  
• Brack, T., Thuer, I., Clarenbach, C. F., Senn, O., Noll, G., Russi, E. W., Bloch, K. E. (2007). Daytime Cheyne-Stokes Respiration in Ambulatory Patients With Severe Congestive Heart Failure Is Associated With Increased Mortality. Chest 132: 1463-1471 [Abstract] [Full Text]  
• Parati, G., Lombardi, C., Narkiewicz, K. (2007). Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293: R1671-R1683 [Abstract] [Full Text]  
• Stanchina, M. L., Ellison, K., Malhotra, A., Anderson, M., Kirk, M., Benser, M. E., Tosi, C., Carlisle, C., Millman, R. P., Buxton, A. (2007). The Impact of Cardiac Resynchronization Therapy on Obstructive Sleep Apnea in Heart Failure Patients: A Pilot Study. Chest 132: 433-439 [Abstract] [Full Text]  
• Dernaika, T., Tawk, M., Nazir, S., Younis, W., Kinasewitz, G. T. (2007). The Significance and Outcome of Continuous Positive Airway Pressure-Related Central Sleep Apnea During Split-Night Sleep Studies. Chest 132: 81-87 [Abstract] [Full Text]  
• Olson, L. J., Somers, V. K. (2007). Treating Central Sleep Apnea in Heart Failure: Outcomes Revisited. Circulation 115: 3140-3142 [Full Text]  
• Arzt, M., Floras, J. S., Logan, A. G., Kimoff, R. J., Series, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., Smilovitch, M., Ryan, C., Tomlinson, G., Bradley, T. D., for the CANPAP Investigators, (2007). Suppression of Central Sleep Apnea by Continuous Positive Airway Pressure and Transplant-Free Survival in Heart Failure: A Post Hoc Analysis of the Canadian Continuous Positive Airway Pressure for Patients With Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115: 3173-3180 [Abstract] [Full Text]  
• Franklin, K. A. (2007). Sleep apnoea screening in heart failure? Not until benefit is proven!. Eur Respir J 29: 1073-1074 [Full Text]  
• Noda, A., Izawa, H., Asano, H., Nakata, S., Hirashiki, A., Murase, Y., Iino, S., Nagata, K., Murohara, T., Koike, Y., Yokota, M. (2007). Beneficial Effect of Bilevel Positive Airway Pressure on Left Ventricular Function in Ambulatory Patients With Idiopathic Dilated Cardiomyopathy and Central Sleep Apnea-Hypopnea: A Preliminary Study. Chest 131: 1694-1701 [Abstract] [Full Text]  
• Lang, C. C, Mancini, D. M (2007). Non-cardiac comorbidities in chronic heart failure. Heart 93: 665-671 [Abstract] [Full Text]  
• Grassi, G., Seravalle, G., Trevano, F. Q., Scopelliti, F., Dell'Oro, R., Bolla, G., Mancia, G. (2007). Response to Sympathetic Activity, Heart Failure, Obesity, and Metabolic Syndrome: Is There Any Role for Sleep Apnea?. Hypertension 49: e39-e39 [Full Text]  
• Javaheri, S., Shukla, R., Zeigler, H., Wexler, L. (2007). Central Sleep Apnea, Right Ventricular Dysfunction, and Low Diastolic Blood Pressure Are Predictors of Mortality in Systolic Heart Failure. J Am Coll Cardiol 49: 2028-2034 [Abstract] [Full Text]  
• Wolkove, N., Elkholy, O., Baltzan, M., Palayew, M. (2007). Sleep and aging: 2. Management of sleep disorders in older people. CMAJ 176: 1449-1454 [Abstract] [Full Text]  
• Smith, L. A., Vennelle, M., Gardner, R. S., McDonagh, T. A., Denvir, M. A., Douglas, N. J., Newby, D. E. (2007). Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J 28: 1221-1227 [Abstract] [Full Text]  
• Le Jemtel, T. H., Jelic, S. (2007). Seek and Treat Obstructive Sleep Apnea in Heart Failure. J Am Coll Cardiol 49: 1632-1633 [Full Text]  
• Wang, H., Parker, J. D., Newton, G. E., Floras, J. S., Mak, S., Chiu, K.-L., Ruttanaumpawan, P., Tomlinson, G., Bradley, T. D. (2007). Influence of Obstructive Sleep Apnea on Mortality in Patients With Heart Failure. J Am Coll Cardiol 49: 1625-1631 [Abstract] [Full Text]  
• Garrigue, S., Pepin, J.-L., Defaye, P., Murgatroyd, F., Poezevara, Y., Clementy, J., Levy, P. (2007). High Prevalence of Sleep Apnea Syndrome in Patients With Long-Term Pacing: The European Multicenter Polysomnographic Study. Circulation 115: 1703-1709 [Abstract] [Full Text]  
• Allen, L. A., O'Connor, C. M. (2007). Management of acute decompensated heart failure. CMAJ 176: 797-805 [Abstract] [Full Text]  
• Eckert, D. J., Jordan, A. S., Merchia, P., Malhotra, A. (2007). Central Sleep Apnea: Pathophysiology and Treatment. Chest 131: 595-607 [Abstract] [Full Text]  
• Moss, M. (2006). Clinical Year in Review III: Critical Care, Mechanical Ventilation, Sleep Medicine, and Lung Cancer. Proc Am Thorac Soc 3: 645-649 [Full Text]  
• Javaheri, S. (2006). Long-term Efficacy of Acetazolamide on Cheyne-Stokes Respiration in Congestive Heart Failure.. Am. J. Respir. Crit. Care Med. 174: 479a-4480 [Full Text]  
• Vazir, A., Morrell, M. J., Simonds, A. K. (2006). From the authors. Eur Respir J 28: 459-460 [Full Text]  
• Ingelsson, E., Bjorklund-Bodegard, K., Lind, L., Arnlov, J., Sundstrom, J. (2006). Diurnal blood pressure pattern and risk of congestive heart failure.. JAMA 295: 2859-2866 [Abstract] [Full Text]  
• Arzt, M., Bradley, T. D. (2006). Treatment of Sleep Apnea in Heart Failure. Am. J. Respir. Crit. Care Med. 173: 1300-1308 [Abstract] [Full Text]  
• Horner, R. L., Bradley, T. D. (2006). Update in sleep and control of ventilation 2005.. Am. J. Respir. Crit. Care Med. 173: 827-832 [Full Text]  
• (2006). Other articles noted. Evid. Based Med. 11: 63-64 [Full Text]  
• Sinha, A.-M., Skobel, E. C., Breithardt, O.-A., Zheng, H., Zhan, H., Wilcox, I., Booth, V., Lattimore, J., Chhajed, P. N., Tamm, M., Strobel, W., Neuberger, H.-R., Bohm, M., Mewis, C., Bradley, T. D., Floras, J. S., Logan, A. G., Yaggi, H. K., Concato, J., Mohsenin, V. (2006). Sleep apnea and heart disease.. NEJM 354: 1086-1089 [Full Text]  
• Ribeiro, J. P. (2006). Periodic Breathing in Heart Failure: Bridging the Gap Between the Sleep Laboratory and the Exercise Laboratory. Circulation 113: 9-10 [Full Text]  
• Malik, I. (2006). JournalScan. Heart 92: 143-144 [Full Text]  
• Pack, A. I. (2006). Advances in Sleep-disordered Breathing. Am. J. Respir. Crit. Care Med. 173: 7-15 [Abstract] [Full Text]  
• (2005). A CPAP Trial in HF Patients with Central Sleep Apnea. Journal Watch Cardiology 2005: 5-5 [Full Text]  
• Somers, V. K. (2005). Sleep -- A New Cardiovascular Frontier. NEJM 353: 2070-2073 [Full Text]